Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by increasing breathlessness. It's a major cause of morbidity and mortality globally, making it crucial for healthcare professionals to understand the nuances of its diagnosis and treatment.
Diagnosis of COPD involves a careful review of the patient's history, physical examination, and confirmation by spirometry. Spirometry measures the amount and speed of air a person can inhale and exhale, providing a critical tool in diagnosing COPD. An FEV1/FVC ratio less than 0.7 after bronchodilator use is indicative of COPD.
Management of COPD has evolved significantly over the years. Pharmacotherapy remains the mainstay of treatment, with bronchodilators being the cornerstone. Inhaled corticosteroids are added for patients with a history of exacerbations. Recently, the role of roflumilast and azithromycin in reducing exacerbations has been recognized.
Non-pharmacological therapies like pulmonary rehabilitation and oxygen therapy have a significant role in managing COPD. Pulmonary rehabilitation improves exercise capacity and quality of life, while long-term oxygen therapy is beneficial in patients with severe resting hypoxemia.
Research into novel treatments for COPD is ongoing. Triple therapy (ICS/LABA/LAMA) has shown promise in reducing exacerbations and improving lung function. Biological therapies targeting eosinophils and neutrophils are also under investigation. Lung volume reduction procedures and endobronchial valves offer new hope for selected patients.
COPD is a complex and challenging disease to manage. The key to effective management lies in accurate diagnosis and a personalized approach to treatment. Understanding the modern treatment approaches, including emerging therapies, is essential for healthcare professionals to improve patient outcomes. The future holds promise for more targeted and effective therapies for COPD.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation